DIRECTOR STOCK OPTION AWARD granted under Appendix B to the OXFORD IMMUNOTEC GLOBAL PLCDirector Stock Option Award • November 8th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 8th, 2013 Company IndustryThis agreement (this “Agreement”) evidences a stock option granted by Oxford Immunotec Global PLC (the “Company”) to the undersigned (the “Optionee”) pursuant to the Company’s 2013 Share Incentive Plan and Appendix B thereto (together, as amended from time to time, the “Plan”).